An investigation on behalf of investors of Cavium Inc (NASDAQ:CAVM) in connection with the proposed takeover was announced and NASDAQ:CAVM stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 12/06/2017 -- The takeover of Cavium Inc is under investigation over potential wrongdoing. The investigation was announced for investors, who currently hold shares of Cavium Inc (NASDAQ:CAVM).
Investors in shares of Cavium Inc (NASDAQ:CAVM) have certain options and should contact the Shareholders Foundation at email@example.com or call 858-779-1554.
The investigation by a law firm concerns whether certain directors of Cavium Inc breached their fiduciary duties owed to NASDAQ:CAVM investors in connection with the proposed acquisition.
On November 20, 2017, Marvell Technology Group Ltd. (NASDAQ: MRVL) and Cavium Inc (NASDAQ:CAVM) announced an agreement, under which Marvell Technology Group Ltd will acquire all outstanding shares of Cavium Inc (NASDAQ:CAVM) common stock in exchange for consideration of $40.00 per share in cash and 2.1757 Marvell Technology Group Ltd common shares for each Cavium Inc (NASDAQ:CAVM) share. Based on a closing price of $20.29 per NASDAQ:MRVL shares on November 17, 2017, investors of Cavium Inc will receive a value of approximately $84.14 per NASDAQ:CAVM.
However, given that at least one analyst has set the high price target for NASDAQ:CAVM shares at $94.00 per share, the investigation concerns whether the offer is unfair to NASDAQ:CAVM stockholders. More specifically, the investigation concerns whether the Cavium Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.
Those who are current investors in Cavium Inc (NASDAQ:CAVM) shares have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels